Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Amendment No. 3 to Form S-4 of Iris Acquisition Corp of our report dated May 13, 2024 (which includes an explanatory paragraph relating to Liminatus Pharma, LLC’s ability to continue as a going concern) relating to the financial statements of Liminatus Pharma, LLC appearing in the Prospectus, which is a part of this Registration Statement.
We also consent to the reference to our Firm under the heading “Experts” in the Prospectus.
/s/ WithumSmith+Brown, PC
WithumSmith+Brown, PC
Whippany, New Jersey
August 6, 2024